Editas Medicine, Inc. (EDIT) NASDAQ

3.04

-0.13(-4.10%)

Updated at October 29 04:00PM

Currency In USD

Valuation

Market Cap104.57M
Enterprise Value8.06M
P/E Ratio-1.08
PEG Ratio-0.17
Price/Sales Ratio7.03
Price/Book Ratio13.37
Enterprise/Revenue5.47
Enterprise/EBITDA-0.94

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-6.09
Operating Margin-6.17

Management Effectiveness

Return On Assets-1.12
Return On Equity-2.42

Income Statement

Revenue32.31M
Revenue/Share0.46
Gross Profit26.51M
EBITDA-233.11M
Net Income-237.09M
Diluted EPS-2.88

Balance Sheet

Total Cash178.5M
Total Cash/Share2.11
Total Debt77.81M
Total Debt/Equity4.05
Current Ratio2.77
Book Value Per Share0.23

Price History

52-Week Change0.66
52-Week High4.54
52-Week Low0.91
Moving Average 50 Days3.21
Moving Average 200 Days2.19

Statistics

Average Volume2.4M
Shares Outstanding89.92M
% Held by Institutions48.97

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A